The complaint was initially filed under the qui tam provision of the False Claims Act. It alleged HudsonValley engaged in two false and fraudulent schemes to defraud the government from 2010 through 2015, including billing for services that were not medically necessary or not performed and routinely waiving beneficiaries’ co-payments and billing the co-payments to Medicare.
As part of the settlement, Hudson Valley admitted, acknowledged and accepted responsibility for engaging in certain conduct during the time frame, including: routinely waiving Medicare beneficiaries’ co-payments without an individualized documented determination of financial hardship, billing Medicare for the waived copayments and overbilling Medicaid and Medicare for evaluation and management services codes, in addition to billing for routine procedures without providing proper documentation of those services, among other claims.
In addition to the government settlement, HudsonValley also entered into a corporate integrity agreement with HHS, under which the company committed to establishing a compliance program and taking further steps to ensure future compliance with CMS rules.
United States District Judge Kenneth Karas approved the settlement agreement Oct. 19.
More articles on legal and regulatory issues:
Trial begins for Utah midwife accused of manslaughter after failing to take woman to hospital
Shreveport hospital operator misses payment deadline
Anonymous ‘hactavist’ charged over 2014 Boston Children’s DDoS attacks
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
